Fasting-Mimicking Diet For CKD: A Simple Guide

Chronic kidney disease (CKD) is common, quiet, and costly. You can feel fine while your kidneys slowly lose filtering power, only discovering trouble years later. That’s why any safe, lifestyle-based strategy that might slow damage gets attention.

In 2024, researchers reported that a kidney-tailored fasting-mimicking diet (FMD) helped injured rat kidneys recover—and in a small human pilot study, monthly 5-day FMD cycles reduced protein in the urine and improved blood vessel function. It’s early, but intriguing—and it opens a practical question: could a carefully designed, supervised FMD become a tool to protect human kidneys? PubMed

Before we dive in, a quick map of CKD. Doctors diagnose CKD when changes in kidney structure or function persist for at least three months and carry health risks.

Staging utilizes two axes: the degree to which your kidneys filter (eGFR, G1–G5) and the amount of albumin that leaks into the urine (A1–A3). Higher stages mean higher risk, even if you feel well. Knowing your stage helps tailor treatment and track progress. KDIGO

II. What is an FMD—and how is it different from the 5:2 diet?

FMD (Fasting-Mimicking Diet)

An FMD is a short, structured, plant-forward, low-protein, low-sugar, relatively higher-fat meal plan designed to imitate the metabolic state of a water fast while still providing some food.

Typical human protocols run 4–7 consecutive days, a few times per year or monthly, with calories ~40–50% of normal on day 1 and ~10–20% on days 2–5. The point is to trigger fasting biology (lower insulin/IGF-1, rise in ketones, cellular cleanup) without full abstinence. PMC

5:2 diet (a form of intermittent fasting)

The 5:2 is simpler: eat normally for five days per week, then restrict your intake to ~500–600 kcal on two non-consecutive days. It doesn’t prescribe particular macronutrients; it’s mainly a calorie pattern for weight control, not a therapeutic, composition-controlled protocol. British Heart Foundation , Diabetes UK

Key differences at a glance

Purpose: FMDs aim to mimic a prolonged fast’s metabolic program (autophagy, IGF-1 reduction) for potential disease-modifying effects; 5:2 mainly creates a weekly calorie deficit for weight loss and metabolic health. PubMed PMC
Structure: FMD = continuous 4–7-day cycles with specific macronutrients; 5:2 = two low-calorie days/week with no set composition. PMC British Heart Foundation
Kidney-specific tweaks: The 2024 kidney study used a low-salt FMD (LS-FMD) designed with sodium restriction—relevant for blood pressure and fluid balance in CKD—whereas standard 5:2 plans don’t necessarily control sodium, potassium, protein, or phosphorus. PubMed
Evidence base: 5:2 has human weight-loss trials and short-term metabolic benefits; FMD has preclinical mechanistic data and early human studies (various conditions) showing favorable risk-factor changes, plus the new CKD-focused rat + small human pilot. Bigger CKD trials are still needed. PMC PubMed+1

Fasting mimicking diet can help chronic kidney disease

III. CKD 101—what’s going wrong?

Your kidneys filter blood, balance electrolytes, regulate blood pressure, and tidy up hormones and acid–base status. CKD is defined as structural or functional kidney abnormalities lasting ≥3 months, often flagged by an eGFR <60 Risks rise as either dial moves—worse filtration or more leakage equals higher chances of progression and heart problems.

CKD treatments focus on blood pressure, RAS blockers, SGLT2 inhibitors, dietary sodium moderation, and glycemic control when relevant. Lifestyle matters throughout. KDIGO+1

eGFR (estimated glomerular filtration rate)

What it is: a calculated estimate of how well the kidneys filter blood, reported in mL/min/1.73 m². It’s derived from a blood creatinine test (and sometimes cystatin C), plus age and sex. It’s an estimate—trends over time matter. National Kidney Foundation NIDDK
Where to find it on labs: usually on the Basic Metabolic Panel (BMP) or Comprehensive Metabolic Panel (CMP) page, listed next to creatinine as “eGFR” or “eGFR (CKD-EPI 2021)”. Some reports say eGFRcr (creatinine only) or eGFRcr-cys (creatinine + cystatin C). KDIGO classifies eGFR into G1–G5 categories for CKD staging. National Kidney Foundation KDIGO

Albuminuria (urine albumin loss)

What it is: the amount of the blood protein albumin leaking into urine—an early sign of kidney damage. The preferred test is the urine albumin-to-creatinine ratio (uACR) from a spot urine sample (no 24-hour urine collection is needed). Results are in mg/g. Categories: A1 <30 mg/g, A2 30–300 mg/g, A3 >300 mg/g. NIDDK+1 KDIGO
Where to find it on labs: look for “Urine Albumin-Creatinine Ratio,” “uACR,” “Albumin/Creatinine Ratio,” or older terms like “microalbumin/creatinine ratio.” It appears on the urine tests section (not the blood panel). A urine dipstick “protein” line is less precise than uACR. National Kidney Foundation

IV. What did the 2024 kidney FMD study actually show?

Scientists created a low-salt FMD and tested it in rats with glomerular injury. Repeated 5-day cycles reduced protein in the urine, reversed structural damage, and reprogrammed podocytes (the specialized cells that help prevent protein leakage) toward a more resilient, quiescent state.

In a pilot clinical study, human adults with CKD performed one 5-day FMD per month for three months and experienced reduced proteinuria and better endothelial function compared with controls. That matters because proteinuria is both a symptom and a driver of kidney decline.

However, this human study was small and short; it tells us FMD may help, not that it will. Larger, longer trials are essential. PubMed

In the study, the rats were fed a low-salt diet, but in the pilot study in humans, the standard FMD diet was used, not the low-salt version.

Here are the kidney pathologies in the 13 human subjects.

IgA nephropathy(4)
Membranoproliferative glomerulonephritis
Membranous nephropathy (3)
Focal segmental glomerulosclerosis (3)
Minimal change disease (2)

How does FMD help in CKD?

Fasting—and fasting-mimicking—shifts the body’s energy program. In both animals and people, periodic FMD cycles lower IGF-1, raise ketone bodies, and stimulate cellular stress-resistance and cleanup pathways (like autophagy).

In models, they also promote regeneration of certain tissues after re-feeding. For kidneys, the 2024 work suggests FMD reactivates developmental/reparative gene programs in glomerular cells and quiets injured podocytes, potentially reducing leakiness.

The mechanistic stack—characterized by less insulin/IGF-1 signaling, reduced inflammation/oxidative stress, and increased repair—plausibly maps onto CKD biology, although proof in humans remains to be established. PubMed PMC

VI. Potential benefits (and realistic expectations)

Where FMD might help in CKD—based on current evidence and theory:

Proteinuria: The pilot hinted at a reduction after monthly 5-day cycles, which could, in principle, slow the decline. Confirmation needs larger trials. PubMed
Vascular health: Improved endothelial function was observed; healthier vessels benefit the kidneys and the heart. Again, early signal only. PubMed
Metabolic risk factors: In non-CKD populations, FMD cycles have improved risk markers (waist circumference, blood pressure, lipids, and CRP) and lowered IGF-1 levels, trends that could indirectly favor kidney outcomes. Extrapolation to CKD is promising but unproven. PubMed

No study to date shows that FMD prevents dialysis or reverses human CKD long-term. Standard CKD care (blood pressure, albuminuria control, SGLT2 inhibitors when indicated, sodium moderation) remains foundational, with FMD—if used—considered adjunctive and clinician-supervised. KDIGO

FMD is more vegetables and low in protein and carbs. Helpful in CKD

VII. Safety first: who should not try fasting cycles without close supervision?

Even modified fasting stresses fluid and electrolyte balance—core issues in CKD.

People with advanced CKD (G4–G5), those prone to hyperkalemia, with unintentional weight loss or malnutrition, pregnancy, eating disorders, brittle diabetes (especially on insulin or sulfonylureas), or on loop/thiazide/RAAS/diuretic combinations need individualized medical guidance.

UK diabetes guidance also emphasizes discussing intermittent fasting with your care team before starting. This caution applies doubly in CKD. Diabetes UK

VIII. If you and your clinician want to explore FMD, what does a cycle look like?

While products and protocols vary, an FMD typically means:

Length: 5 consecutive days. The CKD pilot used one cycle each month for 3 months. PubMed
Calories: About 40–50% of usual on day 1, then 10–20% on days 2–5. Total daily energy might range roughly 700–1100 kcal on day 1 and 300–600 kcal thereafter, depending on body size and plan. PMC
Composition: Plant-forward, low-protein, low-sugar, relatively higher-fat, with attention to low sodium for CKD (as in the kidney study). Potassium and phosphorus targets should be set in consultation with a renal dietitian, based on your laboratory results and stage of disease. PubMed PMC
Between cycles, return to a balanced, kidney-friendly pattern (Mediterranean-style, sodium-aware, protein-individualized) and your usual medications, unless your clinician adjusts them.

How this differs from 5:2 in practice:

5:2 spreads restriction across the calendar (two low-cal days weekly), is agnostic about macros, and aims chiefly at weight loss.
FMD compresses restriction into a continuous multi-day window, prescribes macros, and tries to induce a specific fasting physiology that might yield organ-level effects. British Heart Foundation PMC

IX. What to monitor (with your care team)

A practical “FMD-in-CKD” monitoring plan might include:

Before the first cycle: eGFR/creatinine, urine albumin-to-creatinine ratio, electrolytes (potassium, bicarbonate), blood pressure, weight, and nutrition screen. KDIGO
During each 5-day cycle: Daily blood pressure, weight, symptoms (dizziness, cramps, swelling, palpitations). Discuss whether to hold or adjust diuretics, RAAS blockers, SGLT2 inhibitors, or insulin on fasting days to reduce risks of dehydration, hypotension, hypoglycemia, or electrolyte shifts. (Your team will individualize this.) KDIGO
After each cycle, re-check electrolytes if you have a history of abnormalities; track urine protein and blood pressure over the 3-month course to see if trends are heading in the right direction. If they’re not, stop.

X. Where the 5:2 diet fits

The 5:2 can be a simpler step for people focused on weight loss and insulin sensitivity. Trials in overweight adults show intermittent energy restriction (two very-low-calorie days per week) can match or beat daily calorie cuts for short-term fat loss and insulin resistance.

But because 5:2 doesn’t regulate sodium, potassium, phosphorus, or protein, it’s not kidney-specific. If you live with CKD and want to try 5:2, do it with renal-savvy dietary guidance so those nutrients—and your medications—are handled safely. PMC

XI. The bottom line

FMDs are short, composition-controlled diets engineered to flip on fasting biology without total fasting.
In a 2024 kidney-focused study, FMD cycles reduced proteinuria and improved endothelial function in a small human pilot, and reversed rat glomerular injury, with signs of podocyte reprogramming. That’s biologically exciting but still preliminary for people. PubMed
The 5:2 diet is a weight-management pattern (two ~500–600-kcal days/week) that can improve metabolic health but is not tailored to CKD nutrition needs. British Heart Foundation
If you’re considering FMD (or 5:2) with CKD, do it under the supervision of a clinician and a renal dietitian, with clear lab and blood pressure monitoring, and do not replace proven CKD therapies.

Takeaway:

FMDs are not just “another fasting fad.” They’re tightly designed, short bouts of low-calorie, low-protein, low-sugar eating that may switch on kidney-friendly repair programs—according to early evidence.

The 5:2 diet, while useful for weight loss, is a different approach and not specifically tailored for the kidneys. If you have CKD and are curious, loop in your nephrologist and a renal dietitian first, and treat any fasting plan as an adjunct, not a replacement, for guideline-based care.

Don’t Get Sick!

💡 Support This Work

Creating well-researched articles, maintaining this website, and keeping the information free takes time and resources.
If you found this article helpful, please consider donating to support the mission of empowering people to live healthier, longer lives, without relying on medications.

🙏 Every contribution, big or small, truly makes a difference. Thank you for your support!

Follow me on Facebook, Gab, Twitter (formerly known as X), and Telegram.

References:

Villani, Valentina, et al. “A kidney-specific fasting-mimicking diet induces podocyte reprogramming and restores renal function in glomerulopathy.” Science Translational Medicine, vol. 16, no. 724, 30 Oct. 2024, eadl5514. American Association for the Advancement of Science. https://doi.org/10.1126/scitranslmed.adl5514
Boccardi, Virginia, et al. “The Potential of Fasting-Mimicking Diet as a Preventive and Curative Strategy for Alzheimer’s Disease.” Biomolecules, vol. 13, no. 7, 2023, p. 1133. https://doi.org/10.3390/biom13071133. PMC
Brandhorst, Sebastian, et al. “A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan.” Cell Metabolism, vol. 22, no. 1, 2015, pp. 86–99. https://doi.org/10.1016/j.cmet.2015.05.012. PubMed
Harvie, Michelle N., et al. “The Effect of Intermittent Energy and Carbohydrate Restriction v. Daily Energy Restriction on Weight Loss and Metabolic Disease Risk Markers in Overweight Women.” British Journal of Nutrition, vol. 110, no. 8, 2013, pp. 1534–1547. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857384/. PMC
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. “KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.” Kidney International, vol. 105, suppl. 4S, 2024, S117–S314. https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf. KDIGO
Longo, Valter D., and Mark P. Mattson. “Fasting: Molecular Mechanisms and Clinical Applications.” Cell Metabolism, vol. 19, no. 2, 2014, pp. 181–192. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946160/. PMC
For 5:2 basics (patient-friendly summaries):
British Heart Foundation. “Is the 5:2 Diet a Good Way to Lose Weight? – Ask the Expert.” Heart Matters Magazine, 2023. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/nutrition/ask-the-expert/fast-diet. British Heart Foundation
Diabetes UK. “Intermittent Fasting Diets for Type 2 Diabetes Remission.” 2024. https://www.diabetes.org.uk/about-diabetes/type-2-diabetes/remission/intermittent-fasting-for-remission. Diabetes UK

As an Amazon Associate, I earn from qualifying purchases

Discover more from Don't Get Sick!

Subscribe to get the latest posts sent to your email.

Fasting Mimicking Diet (FMD) and Chronic Kidney Disease (CKD): A Simple Guide

I. Why talk about fasting and kidneys now?